The role of parental preferences in the management of fever without source among 3- to 36-month-old children: A decision analysis

Pediatrics

Volumn 117, Issue 4, 2006, Pages 1067-1076

  Madsen, Kristine A ^a,d   Bennett, Jonathan E ^b   Downs, Stephen M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Child; Decision making; Fever of unknown origin; Parental attitudes; Patient doctor communication

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE; VACCINE; ANTIINFECTIVE AGENT;

ARTICLE; BACTEREMIA; BLOOD CELL COUNT; BLOOD CULTURE; CONTROLLED STUDY; DEATH; FEVER; HUMAN; INFANT; LEUKOCYTE COUNT; MEDICAL DECISION MAKING; MENINGITIS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PARENTAL ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT; STREPTOCOCCUS INFECTION; SURVIVAL; BACTERIAL MENINGITIS; BLOOD; DECISION MAKING; DECISION SUPPORT SYSTEM; MICROBIOLOGY; PARENT; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PYREXIA IDIOPATHICA; SURVIVAL RATE; VACCINATION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; BLOOD CELL COUNT; CHILD, PRESCHOOL; CHOICE BEHAVIOR; DECISION SUPPORT TECHNIQUES; FEVER OF UNKNOWN ORIGIN; HUMANS; INFANT; MENINGITIS, PNEUMOCOCCAL; PARENTS; PNEUMOCOCCAL VACCINES; SURVIVAL RATE; VACCINATION;

EID: 33646379610     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-1865     Document Type: Article

References (53)

1. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics. 1993;92:1-12
2. Baraff LJ, Schriger DL, Bass JW, et al. Management of the young febrile child: commentary on practice guidelines. Pediatrics. 1997;100:134-136
3. Bauchner H, Pelton SI. Management of the young febrile child: a continuing controversy. Pediatrics. 1997;100:137-138
4. Kramer MS, Shapiro ED. Management of the young febrile child: a commentary on recent practice guidelines. Pediatrics. 1997;100:128-134
5. Downs SM, McNutt RA, Margolis PA. Management of infants at risk for occult bacteremia: a decision analysis. J Pediatr. 1991;118:11-20
6. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children: United States, 1987-1995. MMWR Morb Mortal Wkly Rep. 1996;45:901-906
7. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195
8. Black SB, Shinefield HR, Hansen J, et al. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2001;20:1105-1107
9. Halasa NB, Griffin MR, Zhu Y, et al. Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less than five years of age. Pediatr Infect Dis J. 2002;21:1023-1028
10. Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA. 2002;287:3103-3109
11. Lee GM, Fleisher GR, Harper MB. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics. 2001;108:835-844
12. Yamamoto LG. Revising the decision analysis for febrile children at risk for occult bacteremia in a future era of widespread pneumococcal immunization. Clin Pediatr. 2001;40:583-594
13. Bennett JE, Sumner WII, Downs SM, et al. Parents' utilities for outcomes of occult bacteremia. Arch Pediatr Adolesc Med. 2000;154:43-48
14. Kramer MS, Etezadiamoli J, Ciampi A, et al. Parents versus physicians values for clinical outcomes in young febrile children. Pediatrics. 1994;93:697-702
15. Kramer MS, MacLellan AM, Ciampi A, et al. Parents' vs physicians' utilities (values) for clinical outcomes in potentially bacteremic children. J Clin Epidemiol. 1990;43:1319-1325
16. Alpern ER, Alessandrini EA, Bell LM, et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics. 2000;106:505-511
17. Fleisher GR, Rosenberg N, Vinci R, et al. Intramuscular versus oral antibiotic-therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr. 1994;124:504-512
18. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med. 1998;152:624-628
19. Kuppermann N, Fleisher GR, Jaffe DM. Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med. 1998;31:679-687
20. Kuppermann N. Occult bacteremia in young febrile children. Pediatr Clin North Am. 1999;46:1073
21. Harper MB, Bachur R, Fleisher GR. Effect of antibiotic therapy on the outcome of outpatients with unsuspected bacteremia. Pediatr Infect Dis J. 1995;14:760-767
22. Jaffe DM, Tanz RR, Davis AT, et al. Antibiotic administration to treat possible occult bacteremia in febrile children. N Engl J Med. 1987;317:1175-1180
23. Rothrock SG, Harper MB, Green SM, et al. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta-analysis. Pediatrics. 1997;99:438-444
24. Katz BZ, Shapiro ED. Predictors of persistently positive blood cultures in children with "occult" Salmonella bacteremia. Pediatr Infect Dis. 1986;5:713-714
25. Edwards KM, Jones LM, Stephens DS. Clinical features of mild systemic meningococcal disease with characterization of bacterial isolates. Clin Pediatr (Phila). 1985;24:617-620
26. Sullivan TD, LaScolea LJ Jr. Neisseria meningitidis bacteremia in children: quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy. Pediatrics. 1987;80:63-67
27. Carroll WL, Farrell MK, Singer JI, et al. Treatment of occult bacteremia: a prospective randomized clinical trial. Pediatrics. 1983;72:608-612
28. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993;12:389-394
29. Jacobs NM, Lerdkachornsuk S, Metzger WI. Pneumococcal bacteremia in infants and children: a ten-year experience at the Cook County Hospital with special reference to the pneumococcal serotypes isolated. Pediatrics. 1979;64:296-300
30. Laxer RM, Marks MI. Pneumococcal meningitis in children. Am J Dis Child. 1977;131:850-853
31. Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multi-center surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102:1087-1097
32. Fellick JM, Sills JA, Marzouk O, et al. Neurodevelopmental outcome in meningococcal disease: a case-control study. Arch Dis Child. 2001;85:6-11
33. Bedford H, de Louvois J, Halket S, et al. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ. 2001;323:533-536
34. Meadow WL, Schneider H, Beem MO. Salmonella enteritidis bacteremia in childhood. J Infect Dis. 1985;152:185-189
35. Dashefsky B, Teele DW, Klein JO. Unsuspected meningococcemia. J Pediatr. 1983;102:69-72
36. Kuppermann N, Malley R, Inkelis SH, et al. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics. 1999;103(2). Available at: www.pediatrics.org/cgi/ content/full/103/2/e20
37. Alpern ER, Alessandrini EA, McGowan KL, et al. Serotype prevalence of occult pneumococcal bacteremia. Pediatrics. 2001;108(2). Available at: www.pediatrics.org/cgi/content/full/108/2/e23
38. Hausdorff WP, Bryant J, Kloek C, et al. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis. 2000;30:122-140
39. Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30:100-121
40. Babl FE, Pelton SI, Theodore S, et al. Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades. Clin Infect Dis. 2001;32:1155-1161
41. Rudolph AH, Price EV. Penicillin reactions among patients in venereal disease clinics: a national survey. JAMA. 1973;223:499-501
42. Tompkins RK, Burnes DC, Cable WE. An analysis of the cost-effectiveness of pharyngitis management and acute rheumatic fever prevention. Ann Intern Med. 1977;86:481-492
43. Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet. 1999;353:1157-1158
44. Keeney R, Raiffa H. Decisions With Multiple Objectives: Preferences and Tradeoffs. New York, NY: John Wiley & Sons; 1976
45. Kassirer JP, Pauker SG. The toss-up. N Engl J Med. 1981;305:1467-1469
46. National Center for Injury and Prevention. Web-Based Injury Statistics Query and Reporting System. Available at: www.cdc.gov/ncipc/wisqars. Accessed February 16, 2006
47. American College of Emergency Physicians Clinical Policies Committee, American College of Emergency Physicians Clinical Policies Subcommittee on Pediatric Fever. Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med. 2003;42:530-545
48. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med. 2000;36:602-614
49. Glassman PA, Rolph JE, Petersen LP, et al. Physicians' personal malpractice experiences are not related to defensive clinical practices. J Health Polit Policy Law. 1996;21:219-241
50. Zimmerman RK, Schlesselman JJ, Mieczkowski TA, et al. Physician concerns about vaccine adverse effects and potential litigation. Arch Pediatr Adolesc Med. 1998;152:12-19
51. Burstein JL, Fleisher GR. Does recent vaccination increase the risk of occult bacteremia? Pediatr Emerg Care. 1994;10:138-140
52. Romano A, Torres MJ, Namour F, et al. Immediate hypersensitivity to cephalosporins. Allergy. 2002;57(suppl 72):52-57
53. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113:443-449